Arun Kumar

Arun Kumar

Asst Professor - Adj

379, Kowalewski Hall
3255 Eden Ave
Cincinnati, Ohio 45229

Professional Summary

Arun Kumar is an Assistant Professor in the division of Pharmacy Practice and Administrative Sciences at James L. Winkle College of Pharmacy at the University of Cincinnati. He completed his Ph.D. at the University of Minnesota, Twin Cities in the pharmacoepidemiology discipline in 2021. Dr. Kumar’s research work includes the assessment of the safety and effectiveness of medications used in cardiovascular diseases in the real-world population. Broadly, his research work involves the use of large secondary databases with the application of advanced statistical and epidemiologic methods to assess causal relationships. His research interests also encompass the application of health economics principles for informed decision-making by healthcare providers.


Ph.D.: University of Minnesota, College of Pharmacy Minneapolis, Minnesota, 2021 (Social and Administrative Pharmacy (SAPh))

M.S.: St. John’s University, College of Pharmacy and Health Sciences Queens, NY, 2017 (Pharmacy Administration)

PharmD: Vels University, School of Pharmaceutical Sciences Chennai, India, 2012 (Clinical Pharmacy)

Research and Practice Interests

Pharmacoepidemiology and Drug Safety, Evidence-Based Medicine, Systematic Reviews and Meta-Analysis, Claims Data Analysis, Health Economics & Outcomes Research (HEOR), Value Proposition, and Economic Modeling, Decision Analytical Modeling

Positions and Work Experience

2013 -2015 Assistant Professor, ISF College of Pharmacy, Moga, Punjab, India

2015 -2017 Graduate Teaching Assistant, St. John’s University, College of Pharmacy and Health Sciences, Queens, NY

2017 -2021 Research/Teaching Assistant, University of Minnesota, College of Pharmacy, Minneapolis, Minnesota

Research Support

Investigators:Heaton, Pamela; Hincapie Echeverri, Ana Lucia; Kumar, Arun 01-01-2022 -12-31-2025 Eli Lilly and Company Scientific Deliverables to Support Observational Research Methods with Existing Claims or EMR Databases Role:Collaborator 0.00 Hold Level:Industry

Grant: #Grant Agreement 72085 Investigators:Hincapie Echeverri, Ana Lucia; Kumar, Arun; Metzger, Anne 04-01-2022 -01-31-2023 Community Pharmacy Foundation Evaluation of Ohio Pharmacist Providers Law Role:Collaborator 13959.00 Hold Level:Non Profit


Published Abstracts

Kumar, A., Lutsey, P. L., Peter, W. S., Schommer, J. C., & Farley, J. F. (2021. ) Trends in Prescription of P2Y12 Inhibitors Following Revascularization in Coronary Heart Disease .[Abstract]Value in Health, 24, S76-S77Author

Kumar, A., Berg, H., Rivers, Z., Mandic, P. K., Yang, J., & Farley, J. F. (2021. ) Cost-Effectiveness Analysis of Pharmacogenetic Testing in Opioid Analgesia in Pediatric Population Undergoing Surgery .[Abstract]Value in Health, 24, S175

Kumar A, Wu W (2019. ) Health-Related Quality of Life of Stroke Survivors Compared to Non-Stroke Individuals among African Americans in the United States: A Nationally Representative Propensity Score Matched Analysis .[Abstract]Value in Health, 22 , S137

Li W, Kumar A, Muzumdar J, Wu W (2019. ) Association between Perceived Risk and Willingness to Pay Thresholds among Interventions for Common Diseases .[Abstract]Value in Health, 22, S263

Farley JF, Kumar A, Urick B, Domino ME (2018. ) Medical Home Enrollment and Quality of Care: Population Estimates from the U.S. Medical Expenditure Panel Survey .[Abstract]Pharmacoepidemiology and Drug Safety , Vol. 27 ,443-443

Kumar, A., Wu, W., & Nili, M. (2016. ) Cost-Effectiveness of Apixaban (Novel Oral Anti-Coagulant) Compared with Conventional Therapy for Stroke Prophylaxis among Renal Impaired Patients with Atrial-Fibrillation from Perspective of Us Third-Party Payer .[Abstract]Value in Health, 19(3), A47

Nili, M., Wu, W., & Kumar, A (2016. ) Cost-effectiveness analysis of dulaglutide compared with insulin glargine add on to insulin lispro in treatment of type 2 diabetes: a us third-party payer perspective .[Abstract]Value in Health, 19(3), A203

Peer Reviewed Publications

Kumar, A., Talwar, A., Farley, J. F., Muzumdar, J., Schommer, J. C., Balkrishnan, R., & Wu, W. (2019. ) Fondaparinux Sodium Compared With Low‐Molecular‐Weight Heparins for Perioperative Surgical Thromboprophylaxis: A Systematic Review and Meta‐analysis.Journal of the American Heart Association, , 8(10), e012184. , More Information

Farley, J. F., Kumar, A., & Urick, B. Y. (2019. ) Measuring adherence: a proof of concept study for multiple medications for chronic conditions in alternative payment models.Pharmacy, 7(3), 81, , More Information

Farley, J. F., Kumar, A., Urick, B. Y., & Domino, M. E. (2019. ) Patient-centered Medical Homes and Preventive Service Use. American Journal of Managed Care .American Journal of Managed Care, 25(5), e153-e159., ,

Devi, B. R., Syed-Abdul, S., Kumar, A., Iqbal, U., Nguyen, P. A., Li, Y. C. J., & Jian, W. S. (2015. ) mHealth: An updated systematic review with a focus on HIV/AIDS and tuberculosis long-term management using mobile phones.Computer methods and programs in Biomedicine, , 122(2), 257-265. , More Information

Praveen, K. G., and K. Arun (2013. ) Drug utilization and evaluation of HMG-co A reductase inhibitors in a tertiary care teaching hospital .Indian Journal of Pharmacy Practice 6 (4) , ,

Contact Information

Academic - 379, Kowalewski Hall
3255 Eden Ave
Cincinnati  Ohio, 45229